RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

CMS is recalculating all MA Star Ratings for 2024. Here's why.


Editor's note: This popular story from the Daily Briefing's archives was republished on June 21, 2024.

CMS on Thursday announced that it will review all Medicare Advantage (MA) Star Ratings for 2024, after two court cases found the agency improperly modified the way it assesses quality.

CMS to adjust Medicare Advantage Star Ratings

Any MA plan that earns at least 3.5 out of 5 stars qualifies for a bonus from CMS. This extra funding is important to the MA market strategy of utilizing bonus money from CMS to provide lower out-of-pocket costs and supplemental benefits for patients, Modern Healthcare reports.

Last week, a federal judge ruled that CMS had erred in implementing some of its technical changes for the 2024 Star Ratings, which will affect payments in 2025. The judge ordered CMS to recalculate the ratings for SCAN Health Plan, the plaintiff in the case, which SCAN says will increase its 2025 Medicare payments by around $250 million.

A separate judge in a different case involving Elevance Health made a similar ruling a few days later. However, the judge limited the scope of the ruling to one particular Elevance plan.

Following the cases, CMS said it will recalculate its 2024 quality ratings. The agency said it will only apply the new results if a plan's rating goes up under the revised methodology. If a plan's rating goes down, the change will not be implemented.

CMS also said any MA carriers whose Star Ratings are increased will be allowed to resubmit their bids for next year and must notify CMS by Tuesday and file revised submissions by June 28.

CMS didn't specify how many contracts it recalculated or for which companies, and the agency didn't disclose how much more in quality bonuses it will pay out. CMS also didn't specify how it intends to calculate Star Ratings next year, which are slated to be released in October.

According to an analysis by Baltimore Health Analytics, 60 contracts covering 1.9 million enrollees from 40 insurers will receive higher ratings. And according to an analysis by Hyperlift Logic, CMS will have to pay an additional $1.3 billion in bonus payments.

In addition, an analysis from TD Cowen found that Elevance is slated to receive $22 million from CMS, or an additional $12 per member per month. TD Cowen estimated that Aetna will receive the smallest reward at $6.5 million, or $1.90 per member per month. (Tepper, Modern Healthcare, 6/13; Mathews, Wall Street Journal, 6/13; Herman, STAT+ [subscription required], 6/14; Tepper, Modern Healthcare, 6/17)


Advisory Board's take

The impact of CMS' Star Rating recalculation (and 3 ways health plans should respond)

By Mallory Kirby

CMS' recalculation of 2024 Star Ratings deals a blow to the agency's efforts to increase affordability and more meaningfully delineate value in the MA program. The recalculations and potential $1.3 billion in resulting bonus payments — a direct response to successful litigation from SCAN Health Plan and Elevance Health challenging their 2024 Star calculations and payments — is likely a welcome respite for MA plans in a year defined by provider contracting disputes and financial headwinds. However, we don't expect this to be the last change CMS makes to the Star Rating calculation process.  

We know that changes to Stars are part of a broader CMS push to rein in MA spending and better align the program with CMS' definition of value. Like other controversial changes or proposals, CMS' ambition is often tempered by plan backlash or, in this case, litigation. While the two federal lawsuits and CMS' decision to recalculate this year's Star Ratings pave the way for higher payments, CMS may still appeal the decisions and will certainly consider how best to calculate and distribute future Star Ratings.  

While higher Star Ratings and increased bonus payments will surely be welcomed by the 60 MA contracts who received a recalculated increase, this move is not without issues for plans. Plans who wish to resubmit 2025 MA bids with their higher Star Ratings face increased logistical and administrative burden associated with repeat bid submission, and a potential distraction from other strategic priorities while they scramble to resubmit.  

In response to CMS' 2024 Star Rating recalculation — and in preparation for unknown moves ahead — health plans must:

  • Watch how other plans respond, including through new litigation. These decisions could set the precedent for future legal decisions (such as Zing Health's ongoing lawsuit).
  • Prepare for ongoing and future policy decisions. Change remains the only constant in Star Rating calculations. Plans must protect or build up their internal expertise dedicated to anticipating and interpreting new rules from CMS.
  • Reground in operational excellence. Star calculations are ever-changing, but MA leaders can prepare by advocating for a year-round, institution-wide focus on quality. Now more than ever, plans need holistic quality programming that retains enough flexibility in staff and resourcing for targeted interventions. Plans should also align Star efforts with risk management and care management teams for comprehensive member support.

Advisory Board resources on Medicare Advantage

Advisory Board has a variety of resources on MA, including:


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

Mallory Kirby

Director, Health plan research

TOPICS

INDUSTRY SECTORS

Related Resources

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.